Clinical Trial Update: A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated carboplatin plus paclitaxel with MK-0683 in chemotherapy-naive non-small cell lung cancer; the study was terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• MK0683 (MK-0683)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2009-06-01